What the superinvestors bought and sold in 2025 Q4
2025 Q4
137 of 137 filedThe quarter at a glance
87 of 136 managers were net sellers. Setting price aside, they took $12.7B out, led by Information Technology (−$6.1B), while adding to Energy (+$4.9B). BN was the most widely bought stock (12 bought, 0 sold); GOOGL / GOOG the most widely sold (36 sold, 17 bought).
Net buyers
46 of 136 managers
87 sold more than they bought · 3 about even
Net bought
−$12.7B
Price moves taken out; prices alone moved the book +$37.7B.
Positions opened
766
747 closed out. IPOs, spin-offs and mergers left out.
Combined book, last quarter
+2.6%
SPY +2.4%,
0.2 pts ahead.
Price only.
Most bought and sold
Ranked by net dollars bought or sold, with price moves taken out. Open a stock to see who.
Most bought
-
1 BN Brookfield Corp. 12 bought · 0 sold +$3B
Bought by
- Josh Tarasoff - Greenlea Lane Capital Management added 19.0% → 18.9%
- Chuck Akre - Akre Capital Management added 13.1% → 13.5%
- Steven Check - Check Capital Management added 6.6% → 5.9%
- Stephen Mandel - Lone Pine Capital added 5.1% → 5.4%
- Thomas Gayner - Markel Group added 4.9% → 4.8%
- Third Avenue Management added 4.8% → 4.6%
- Dan Loeb - Third Point added 3.6% → 3.9%
- Arnold Van Den Berg - Van Den Berg Management I added 3.5% → 3.1%
and 4 more
Sold by
No manager sold.
-
2 CRM Salesforce Inc. 6 bought · 6 sold +$2.9B
Bought by
- Valueact Capital - Valueact Holdings added 11.6% → 11.3%
- Bill Nygren / Oakmark - Harris Associates L P added 2.7% → 3.3%
- Harry Burn - Sound Shore Management opened 3.2% of book
- Lewis Sanders - Sanders Capital opened 2.6% of book
- First Eagle Investment Management added 1.6% → 2.0%
- George Soros - Soros Fund Management added 1.6% → 1.6%
Sold by
- Starboard Value cut 5.5% → 4.7%
- Farallon Capital Management cut 2.4% → 1.6%
- Hillman Capital Management cut 1.7% → 1.7%
- Davidson Kempner Capital Management closed was 0.30%
- Cathie Wood - Ark Investment Management cut 0.11% → 0.09%
- Polen Capital Management cut <0.01% → <0.01%
-
3 TPL Texas Pacific Land Corporati 1 bought · 0 sold +$2B
Bought by
- Murray Stahl - Horizon Kinetics Asset Management added 39.9% → 40.1%
Sold by
No manager sold.
-
4 DASH Doordash Inc. 11 bought · 0 sold +$1.6B
Bought by
- Henry Ellenbogen - Durable Capital Partners added 3.4% → 7.7%
- Ram Parameswaran - Octahedron Capital Management opened 5.3% of book
- Stephen Mandel - Lone Pine Capital opened 4.2% of book
- Philippe Laffont - Coatue Management added 1.6% → 2.5%
- Lee Ainslie - Maverick Capital added 0.02% → 0.87%
- Cathie Wood - Ark Investment Management added 0.34% → 0.46%
- George Soros - Soros Fund Management added 0.41% → 0.37%
- Davidson Kempner Capital Management opened 0.36% of book
and 3 more
Sold by
No manager sold.
-
5 NVDA Nvidia Corporation 19 bought · 10 sold +$1.6B
Bought by
- Brad Gerstner - Altimeter Capital Management added 18.8% → 22.7%
- Grant Wonders - Voyager Global Management added 11.7% → 21.0%
- Ram Parameswaran - Octahedron Capital Management added 7.0% → 11.8%
- Nehal Chopra - Ratan Capital Management added 9.3% → 10.8%
- Marc Stad - Dragoneer Investment Group added 8.6% → 10.8%
- Glen Kacher - Light Street Capital Management added 8.7% → 9.8%
- Duan Yongping - H&H International Investment added 0.76% → 7.7%
- Dan Loeb - Third Point added 5.9% → 7.6%
and 11 more
Sold by
- Mairs & Power cut 9.8% → 8.9%
- Alex Sacerdote - Whale Rock Capital Management cut 7.0% → 2.9%
- Chase Coleman - Tiger Global Management cut 6.8% → 6.9%
- David Tepper - Appaloosa cut 4.8% → 4.6%
- Philippe Laffont - Coatue Management cut 4.5% → 4.3%
- Polen Capital Management cut 3.8% → 4.2%
- Kentucky Trust Co. - Kentucky Trust cut 1.8% → 1.6%
- Davidson Kempner Capital Management cut 1.6% → 0.85%
and 2 more
-
6 WTW Willis Towers Watson PLC 3 bought · 4 sold +$1.5B
Bought by
- Seth Klarman - Baupost Group added 7.9% → 8.5%
- Bill Nygren / Oakmark - Harris Associates L P added 2.4% → 2.3%
- Dodge & Cox added 0.68% → 1.2%
Sold by
- Harry Burn - Sound Shore Management cut 2.8% → 2.4%
- Murphy Pohlad - Murphy Pohlad Asset Management cut 1.6% → 1.4%
- Polen Capital Management cut 0.25% → 0.04%
- Ron Baron - Bamco Inc. (Baron Capital) cut 0.09% → 0.08%
-
7 ICE Intercontinental Exchange In 3 bought · 2 sold +$1.5B
Bought by
- Bill Nygren / Oakmark - Harris Associates L P added 2.8% → 3.2%
- Andreas Halvorsen - Viking Global Investors opened 2.1% of book
- Thomas Gayner - Markel Group added <0.01% → 0.03%
Sold by
- John Armitage - Egerton Capital (UK) closed was 1.8%
- Cathie Wood - Ark Investment Management cut 0.06% → 0.06%
-
8 CHTR Charter Communications, Inc. 5 bought · 3 sold +$1.3B
Bought by
- Grant Wonders - Voyager Global Management added 1.0% → 11.3%
- Dodge & Cox added 1.8% → 1.6%
- Bill Nygren / Oakmark - Harris Associates L P added 1.5% → 1.1%
- First Eagle Investment Management added 0.68% → 1.1%
- Lee Ainslie - Maverick Capital opened 0.05% of book
Sold by
- First Pacific Advisors cut 2.5% → 1.3%
- Wallace Weitz - Weitz Investment Management cut 1.5% → <0.01%
- Richard Pzena - Pzena Investment Management cut 0.36% → 0.07%
-
9 CB Chubb Limited 4 bought · 0 sold +$1.3B
Bought by
- Warren Buffett - Berkshire Hathaway added 3.3% → 3.9%
- David Rolfe - Wedgewood Partners opened 3.3% of book
- Christopher Davis - Davis Selected Advisers added 1.6% → 1.7%
- Andreas Halvorsen - Viking Global Investors opened 0.84% of book
Sold by
No manager sold.
-
10 CVX Chevron Corp. New 3 bought · 2 sold +$1.2B
Bought by
- Warren Buffett - Berkshire Hathaway added 7.1% → 7.2%
- Torray Investment Partners added 2.8% → 3.2%
- Arnold Van Den Berg - Van Den Berg Management I added 0.14% → 0.16%
Sold by
- Mairs & Power cut 0.03% → 0.03%
- Bill Nygren / Oakmark - Harris Associates L P cut <0.01% → <0.01%
Not counted as buying: 179 IPOs, spin-offs and new listings.
Most sold
-
1 BAC Bank America Corp. 0 bought · 13 sold −$4.9B
Sold by
- Guy Spier - Aquamarine Zurich AG closed was 12.5%
- Warren Buffett - Berkshire Hathaway cut 11.0% → 10.4%
- Dan Sundheim - D1 Capital Partners cut 3.3% → 0.64%
- Harry Burn - Sound Shore Management cut 3.2% → 2.8%
- Lee Ainslie - Maverick Capital closed was 2.3%
- Bill Nygren / Oakmark - Harris Associates L P cut 2.2% → 1.4%
- Andreas Halvorsen - Viking Global Investors cut 1.5% → 0.66%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.3%
and 5 more
Bought by
No manager bought.
-
2 AAPL Apple Inc. 2 bought · 10 sold −$3.6B
Sold by
- Duan Yongping - H&H International Investment cut 60.4% → 50.3%
- Warren Buffett - Berkshire Hathaway cut 22.7% → 22.6%
- David Rolfe - Wedgewood Partners cut 7.8% → 7.3%
- Jensen Investment Management cut 7.3% → 8.5%
- Torray Investment Partners cut 1.8% → 1.9%
- Robert Olstein - Olstein Capital Management cut 0.77% → 0.72%
- Glen Kacher - Light Street Capital Management cut 0.46% → 0.42%
- Lee Ainslie - Maverick Capital closed was 0.04%
and 2 more
Bought by
- George Soros - Soros Fund Management added 1.3% → 1.3%
- Ron Baron - Bamco Inc. (Baron Capital) added <0.01% → 0.01%
-
3 GOOGL / GOOG Alphabet 17 bought · 36 sold −$3.1B
Sold by
- Andrew Steginsky - Steginsky Capital cut 31.0% → 36.2%
- Triple Frond Partners cut 14.6% → 11.5%
- Ruane, Cunniff & Goldfarb cut 14.6% → 16.2%
- Lindsell Train cut 13.3% → 16.6%
- First Pacific Advisors cut 13.1% → 13.5%
- Grant Wonders - Voyager Global Management cut 12.5% → 8.5%
- Thomas Russo - Gardner Russo & Quinn cut 12.2% → 13.4%
- Lewis Sanders - Sanders Capital cut 10.1% → 11.5%
and 28 more
Bought by
- Mala Gaonkar - Surgocap Partners added 6.0% → 10.9%
- Alex Sacerdote - Whale Rock Capital Management added 3.4% → 8.4%
- David Tepper - Appaloosa added 4.6% → 8.1%
- Glen Kacher - Light Street Capital Management added 5.0% → 6.5%
- Christopher Davis - Davis Selected Advisers added 4.3% → 5.4%
- Ben Jacobs - Anomaly Capital Management added 1.3% → 4.0%
- Lee Ainslie - Maverick Capital added 0.05% → 3.8%
- John Armitage - Egerton Capital (UK) opened 3.7% of book
and 9 more
-
4 INTU Intuit 3 bought · 14 sold −$2.1B
Sold by
- Dennis Hong - Shawspring Partners cut 11.6% → 6.3%
- Ako Capital cut 6.5% → 2.4%
- Ben Jacobs - Anomaly Capital Management cut 5.0% → 2.0%
- Jensen Investment Management cut 4.6% → 2.8%
- Dev Kantesaria - Valley Forge Capital Management cut 4.3% → 3.3%
- Henry Ellenbogen - Durable Capital Partners closed was 2.2%
- Gavin Baker - Atreides Management closed was 1.8%
- Polen Capital Management cut 1.5% → 1.4%
and 6 more
Bought by
- Torray Investment Partners opened 2.1% of book
- Cathie Wood - Ark Investment Management added 0.19% → 0.31%
- Lee Ainslie - Maverick Capital added <0.01% → 0.05%
-
5 FISV Fiserv, Inc. 8 bought · 13 sold −$2B
Sold by
- Dodge & Cox cut 2.7% → 1.8%
- Francois Rochon - Giverny Capital closed was 2.6%
- Mairs & Power cut 2.1% → 1.1%
- Vulcan Value Partners cut 1.9% → 1.8%
- Hillman Capital Management cut 1.7% → 1.6%
- David Tepper - Appaloosa closed was 1.6%
- Norbert Lou - Punch Card Management closed was 1.5%
- Robert Olstein - Olstein Capital Management closed was 1.4%
and 5 more
Bought by
- Claude Leveille - Courant Investment Management added 8.7% → 11.5%
- Jana Partners Management opened 7.8% of book
- Seth Klarman - Baupost Group added 2.4% → 2.8%
- Bill Nygren / Oakmark - Harris Associates L P added 1.4% → 1.3%
- Samantha Mclemore - Patient Capital Management opened 0.67% of book
- Murphy Pohlad - Murphy Pohlad Asset Management added 0.31% → 0.64%
- Christopher Davis - Davis Selected Advisers opened 0.17% of book
- Mason Hawkins - Southeastern Asset Management opened 0.01% of book
-
6 COF Capital One Finl Corp. 6 bought · 11 sold −$1.6B
Sold by
- Chris James - Meritage Group cut 14.1% → 13.8%
- Abrams Bison - Abrams Bison Investments cut 8.3% → 8.6%
- Clifford Sosin - Cas Investment Partners cut 6.3% → 6.1%
- Andreas Halvorsen - Viking Global Investors cut 4.1% → 1.9%
- Stephen Mandel - Lone Pine Capital cut 4.0% → 4.1%
- Dan Loeb - Third Point cut 3.3% → 3.7%
- Harry Burn - Sound Shore Management cut 3.2% → 2.8%
- Dan Sundheim - D1 Capital Partners cut 2.4% → 1.9%
and 3 more
Bought by
- Christopher Davis - Davis Selected Advisers added 9.3% → 9.4%
- Glenn Greenberg - Brave Warrior Advisors added 4.8% → 5.7%
- Senator Investment Group added 3.2% → 4.6%
- Lee Ainslie - Maverick Capital added 3.1% → 3.4%
- Bill Nygren / Oakmark - Harris Associates L P added 3.1% → 3.3%
- Ron Baron - Bamco Inc. (Baron Capital) added <0.01% → <0.01%
-
7 BK The Bank Of New York Mellon Corp. 0 bought · 6 sold −$1.6B
Sold by
- Dodge & Cox cut 2.0% → 1.6%
- First Eagle Investment Management cut 2.0% → 2.0%
- Tweedy, Browne Co. cut 1.3% → 1.2%
- Bill Nygren / Oakmark - Harris Associates L P cut 0.60% → <0.01%
- Don Yacktman - Yacktman Asset Management cut 0.59% → 0.59%
- Christopher Davis - Davis Selected Advisers cut 0.57% → 0.27%
Bought by
No manager bought.
-
8 GM General Mtrs Co. 2 bought · 7 sold −$1.5B
Sold by
- Greenhaven Associates cut 21.4% → 20.0%
- Harry Burn - Sound Shore Management cut 3.0% → 2.8%
- Samantha Mclemore - Patient Capital Management cut 2.3% → 2.4%
- Andreas Halvorsen - Viking Global Investors cut 2.1% → 1.5%
- Bill Nygren / Oakmark - Harris Associates L P cut 2.1% → 1.8%
- Robert Olstein - Olstein Capital Management cut 0.98% → 0.80%
- Murray Stahl - Horizon Kinetics Asset Management cut <0.01% → <0.01%
Bought by
- Tweedy, Browne Co. added 0.12% → 0.17%
- Kentucky Trust Co. - Kentucky Trust added 0.09% → 0.13%
-
9 META Meta Platforms Inc. 13 bought · 23 sold −$1.5B
Sold by
- Robert Vinall - Rv Capital AG cut 18.8% → 20.9%
- Pat Dorsey - Dorsey Asset Management cut 12.7% → 9.2%
- Triple Frond Partners cut 8.1% → 6.7%
- Philippe Laffont - Coatue Management cut 7.3% → 6.2%
- Stephen Mandel - Lone Pine Capital closed was 7.1%
- Alex Sacerdote - Whale Rock Capital Management cut 6.3% → 4.0%
- Terry Smith - Fundsmith cut 5.8% → 5.3%
- Grant Wonders - Voyager Global Management closed was 5.4%
and 15 more
Bought by
- Valueact Capital - Valueact Holdings added 9.5% → 9.8%
- Nehal Chopra - Ratan Capital Management added 8.5% → 7.9%
- Lewis Sanders - Sanders Capital added 8.6% → 7.6%
- Eric Mandelblatt - Soroban Capital Partners added 4.0% → 6.0%
- David Tepper - Appaloosa added 3.7% → 5.7%
- Dan Sundheim - D1 Capital Partners added 2.3% → 2.3%
- Mairs & Power added 1.8% → 2.0%
- David Katz - Matrix Asset Advisors added 1.9% → 1.9%
and 5 more
-
10 MSFT Microsoft Corp. 19 bought · 22 sold −$1.4B
Sold by
- Robert Karr - Joho Capital cut 37.6% → 37.1%
- Altarock Partners cut 24.3% → 19.7%
- Triple Frond Partners cut 21.7% → 17.7%
- Eric Mandelblatt - Soroban Capital Partners cut 15.6% → 14.0%
- Gates Foundation Trust cut 13.0% → 10.5%
- Vulcan Value Partners cut 11.1% → 10.1%
- Chase Coleman - Tiger Global Management cut 10.5% → 8.9%
- John Armitage - Egerton Capital (UK) cut 9.9% → 9.2%
and 14 more
Bought by
- Chris James - Meritage Group added 16.6% → 19.0%
- Grant Wonders - Voyager Global Management added 12.1% → 14.5%
- Brad Gerstner - Altimeter Capital Management added 7.9% → 9.3%
- Nehal Chopra - Ratan Capital Management added 1.3% → 7.4%
- Estuary Capital Management opened 6.5% of book
- Philippe Laffont - Coatue Management added 5.9% → 6.3%
- Lee Ainslie - Maverick Capital added 6.5% → 6.0%
- Farallon Capital Management added 4.1% → 5.1%
and 11 more
Not counted as selling: 178 mergers and delistings.
Ranked by dollars, single large books set the order: 1 of these 20 names were traded by one or two managers.
Opened and closed
New positions started from zero, and positions sold down to zero. IPOs, spin-offs and mergers are left out.
Opened by the most managers
-
AMZN Amazon.com, Inc. 8 managers avg 4.0% of book · Seth Klarman - Baupost Group, Estuary Capital Management and 6 more
Opened by
- Seth Klarman - Baupost Group opened 9.3% of book
- Estuary Capital Management opened 6.5% of book
- Dennis Hong - Shawspring Partners opened 5.1% of book
- Jensen Investment Management opened 4.1% of book
- Dan Sundheim - D1 Capital Partners opened 2.9% of book
- David Rolfe - Wedgewood Partners opened 2.5% of book
- Andreas Halvorsen - Viking Global Investors opened 1.9% of book
- Thomas Russo - Gardner Russo & Quinn opened <0.01% of book
-
DASH Doordash Inc. 6 managers avg 1.7% of book · Ram Parameswaran - Octahedron Capital Management, Stephen Mandel - Lone Pine Capital and 4 more
Opened by
- Ram Parameswaran - Octahedron Capital Management opened 5.3% of book
- Stephen Mandel - Lone Pine Capital opened 4.2% of book
- Davidson Kempner Capital Management opened 0.36% of book
- Stanley Druckenmiller - Duquesne Family Office opened 0.18% of book
- Kentucky Trust Co. - Kentucky Trust opened 0.02% of book
- First Eagle Investment Management opened <0.01% of book
-
AVGO Broadcom Inc. 6 managers avg 1.6% of book · Estuary Capital Management, Farallon Capital Management and 4 more
Opened by
- Estuary Capital Management opened 6.4% of book
- Farallon Capital Management opened 1.5% of book
- Jensen Investment Management opened 0.97% of book
- Davidson Kempner Capital Management opened 0.41% of book
- George Soros - Soros Fund Management opened 0.41% of book
- Sarah Ketterer - Causeway Capital Management opened <0.01% of book
-
GOOGL / GOOG Alphabet 6 managers avg 1.3% of book · John Armitage - Egerton Capital (UK), Andreas Halvorsen - Viking Global Investors and 4 more
Opened by
- John Armitage - Egerton Capital (UK) opened 3.7% of book
- Andreas Halvorsen - Viking Global Investors opened 2.2% of book
- Nehal Chopra - Ratan Capital Management opened 1.7% of book
- Richard Pzena - Pzena Investment Management opened 0.16% of book
- Senator Investment Group opened 0.14% of book
- Christopher Bloomstran - Semper Augustus Investments Group opened 0.03% of book
-
LYV Live Nation Entertainment In 5 managers avg 5.2% of book · Pat Dorsey - Dorsey Asset Management, Spencer Waxman - Shannon River Fund Management and 3 more
Opened by
- Pat Dorsey - Dorsey Asset Management opened 7.5% of book
- Spencer Waxman - Shannon River Fund Management opened 5.7% of book
- Eric Khrom - Khrom Capital Management opened 5.2% of book
- Sachem Head Capital Management opened 4.1% of book
- Triple Frond Partners opened 3.8% of book
-
LPLA Lpl Financial Holdings, Inc. 5 managers avg 1.7% of book · King Street Capital Management, Senator Investment Group and 3 more
Opened by
- King Street Capital Management opened 5.1% of book
- Senator Investment Group opened 1.4% of book
- John Armitage - Egerton Capital (UK) opened 0.99% of book
- William Von Mueffling - Cantillon Capital Management opened 0.71% of book
- First Eagle Investment Management opened <0.01% of book
-
RKT Rocket Cos Inc. 4 managers avg 3.5% of book · Leon Cooperman - Omega Advisors, Philippe Laffont - Coatue Management and 2 more
Opened by
- Leon Cooperman - Omega Advisors opened 13.5% of book
- Philippe Laffont - Coatue Management opened 0.33% of book
- Ron Baron - Bamco Inc. (Baron Capital) opened 0.07% of book
- George Soros - Soros Fund Management opened <0.01% of book
-
AMD Advanced Micro Devices Inc. 4 managers avg 2.5% of book · Estuary Capital Management, Nehal Chopra - Ratan Capital Management and 2 more
Opened by
- Estuary Capital Management opened 6.5% of book
- Nehal Chopra - Ratan Capital Management opened 1.8% of book
- Glenview Capital Management opened 1.7% of book
- George Soros - Soros Fund Management opened 0.04% of book
-
FISV Fiserv, Inc. 4 managers avg 2.2% of book · Jana Partners Management, Samantha Mclemore - Patient Capital Management and 2 more
Opened by
- Jana Partners Management opened 7.8% of book
- Samantha Mclemore - Patient Capital Management opened 0.67% of book
- Christopher Davis - Davis Selected Advisers opened 0.17% of book
- Mason Hawkins - Southeastern Asset Management opened 0.01% of book
-
ISRG Intuitive Surgical Inc. 4 managers avg 1.6% of book · Mala Gaonkar - Surgocap Partners, Polen Capital Management and 2 more
Opened by
- Mala Gaonkar - Surgocap Partners opened 4.1% of book
- Polen Capital Management opened 2.0% of book
- Mairs & Power opened 0.34% of book
- Francois Rochon - Giverny Capital opened <0.01% of book
Closed out by the most managers
-
META Meta Platforms Inc. 10 managers was avg 3.0% of book · Stephen Mandel - Lone Pine Capital, Grant Wonders - Voyager Global Management and 8 more
Closed by
- Stephen Mandel - Lone Pine Capital closed was 7.1%
- Grant Wonders - Voyager Global Management closed was 5.4%
- Mala Gaonkar - Surgocap Partners closed was 4.3%
- John Armitage - Egerton Capital (UK) closed was 4.2%
- Ben Jacobs - Anomaly Capital Management closed was 3.2%
- Dan Loeb - Third Point closed was 1.8%
- Andreas Halvorsen - Viking Global Investors closed was 1.8%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.4%
and 2 more
-
BABA Alibaba Group Holding, Ltd. 7 managers was avg 1.6% of book · Glen Kacher - Light Street Capital Management, Guy Spier - Aquamarine Zurich AG and 5 more
Closed by
- Glen Kacher - Light Street Capital Management closed was 3.2%
- Guy Spier - Aquamarine Zurich AG closed was 2.7%
- Brad Gerstner - Altimeter Capital Management closed was 2.3%
- Ben Jacobs - Anomaly Capital Management closed was 1.7%
- Philippe Laffont - Coatue Management closed was 0.87%
- Lewis Sanders - Sanders Capital closed was 0.79%
- Polen Capital Management closed was <0.01%
-
SE Sea Ltd 7 managers was avg 1.3% of book · Alex Sacerdote - Whale Rock Capital Management, Stephen Mandel - Lone Pine Capital and 5 more
Closed by
- Alex Sacerdote - Whale Rock Capital Management closed was 2.4%
- Stephen Mandel - Lone Pine Capital closed was 2.4%
- Glen Kacher - Light Street Capital Management closed was 2.1%
- Ryan Packard - Hiddenite Capital Partners closed was 1.3%
- Howard Marks - Oaktree Capital Management closed was 0.39%
- Sarah Ketterer - Causeway Capital Management closed was 0.36%
- Philippe Laffont - Coatue Management closed was 0.29%
-
FISV Fiserv, Inc. 7 managers was avg 1.3% of book · Francois Rochon - Giverny Capital, David Tepper - Appaloosa and 5 more
Closed by
- Francois Rochon - Giverny Capital closed was 2.6%
- David Tepper - Appaloosa closed was 1.6%
- Norbert Lou - Punch Card Management closed was 1.5%
- Robert Olstein - Olstein Capital Management closed was 1.4%
- David Katz - Matrix Asset Advisors closed was 0.94%
- Torray Investment Partners closed was 0.80%
- Ron Baron - Bamco Inc. (Baron Capital) closed was <0.01%
-
FLUT Flutter Entmt PLC 6 managers was avg 2.4% of book · John Armitage - Egerton Capital (UK), Stephen Mandel - Lone Pine Capital and 4 more
Closed by
- John Armitage - Egerton Capital (UK) closed was 3.8%
- Stephen Mandel - Lone Pine Capital closed was 3.2%
- Dan Loeb - Third Point closed was 3.2%
- Henry Ellenbogen - Durable Capital Partners closed was 2.3%
- Senator Investment Group closed was 1.5%
- Farallon Capital Management closed was 0.14%
-
INTU Intuit 6 managers was avg 1.2% of book · Henry Ellenbogen - Durable Capital Partners, Gavin Baker - Atreides Management and 4 more
Closed by
- Henry Ellenbogen - Durable Capital Partners closed was 2.2%
- Gavin Baker - Atreides Management closed was 1.8%
- Philippe Laffont - Coatue Management closed was 1.4%
- Farallon Capital Management closed was 1.4%
- Andreas Halvorsen - Viking Global Investors closed was 0.47%
- George Soros - Soros Fund Management closed was 0.08%
-
KMX Carmax Inc. 5 managers was avg 2.7% of book · Claude Leveille - Courant Investment Management, Francois Rochon - Giverny Capital and 3 more
Closed by
- Claude Leveille - Courant Investment Management closed was 8.8%
- Francois Rochon - Giverny Capital closed was 2.3%
- Wallace Weitz - Weitz Investment Management closed was 1.6%
- Steven Check - Check Capital Management closed was 0.89%
- Ruane, Cunniff & Goldfarb closed was <0.01%
-
VST Vistra Corp. 5 managers was avg 2.0% of book · Situational Awareness, Ryan Packard - Hiddenite Capital Partners and 3 more
Closed by
- Situational Awareness closed was 6.1%
- Ryan Packard - Hiddenite Capital Partners closed was 2.3%
- Stanley Druckenmiller - Duquesne Family Office closed was 1.1%
- Philippe Laffont - Coatue Management closed was 0.25%
- Polen Capital Management closed was <0.01%
-
MDB Mongodb Inc. 5 managers was avg 1.5% of book · Glen Kacher - Light Street Capital Management, Ram Parameswaran - Octahedron Capital Management and 3 more
Closed by
- Glen Kacher - Light Street Capital Management closed was 3.6%
- Ram Parameswaran - Octahedron Capital Management closed was 2.8%
- Lee Ainslie - Maverick Capital closed was 0.57%
- Chase Coleman - Tiger Global Management closed was 0.33%
- Stanley Druckenmiller - Duquesne Family Office closed was 0.14%
-
ZTS Zoetis Inc. 5 managers was avg 0.80% of book · Jensen Investment Management, Ako Capital and 3 more
Closed by
- Jensen Investment Management closed was 1.6%
- Ako Capital closed was 1.4%
- William Von Mueffling - Cantillon Capital Management closed was 0.97%
- Kentucky Trust Co. - Kentucky Trust closed was <0.01%
- Dodge & Cox closed was <0.01%
Where the money went
Net bought by sector, with price moves taken out. Pick a sector to see its names.
- Energy 5.2% weight · −0.2 pts +$4.9B 16 bought · 17 sold
- Real Estate 1.9% weight · +0.1 pts +$4.2B 22 bought · 10 sold
- Industrials 10.8% weight · +0.2 pts +$1.7B 44 bought · 40 sold
- Materials 2.5% weight · +0.1 pts +$855M 24 bought · 20 sold
- Utilities 1.1% weight · no change +$5M 12 bought · 8 sold
- Consumer Discretionary 10.0% weight · −0.3 pts −$1.6B 39 bought · 49 sold
- Consumer Staples 5.1% weight · −0.1 pts −$2.4B 9 bought · 25 sold
- Financials 22.8% weight · +0.4 pts −$4.9B 34 bought · 55 sold
- Communication Services 9.1% weight · no change −$5B 25 bought · 48 sold
- Health Care 10.5% weight · +0.2 pts −$5.2B 31 bought · 38 sold
- Information Technology 21.1% weight · −0.5 pts −$6.1B 42 bought · 54 sold
Financials gained weight (+0.4 pts) even though managers sold $4.9B of it: weight follows price, not buying. Names without a sector (funds, foreign listings, private shares): +$687M.
Who moved the most
The biggest new positions, measured against each manager’s own book, and the managers that traded the most of theirs.
Biggest new bets
- Leon Cooperman - Omega Advisors opened RKT · Rocket Cos Inc. 13.5% of book
- Sachem Head Capital Management opened SATS · Echostar Corp. 13.3% of book
- Alex Roepers - Atlantic Investment Management opened FLS · Flowserve Corp. 12.3% of book
- Valueact Capital - Valueact Holdings opened BLK · Blackrock Inc. 10.6% of book
- Dennis Hong - Shawspring Partners opened BABA · Alibaba Group Holding, Ltd. 10.4% of book
- Seth Klarman - Baupost Group opened AMZN · Amazon.com, Inc. 9.3% of book
Most active managers
- Estuary Capital Management 13 opened · 8 closed · −$33M net 141% of book traded
- Nehal Chopra - Ratan Capital Management 10 opened · 2 closed · +$185M net 109% of book traded
- Spencer Waxman - Shannon River Fund Management 10 opened · 5 closed · −$82M net 95% of book traded
- Sachem Head Capital Management 6 opened · 5 closed · +$465M net 86% of book traded
- Ram Parameswaran - Octahedron Capital Management 6 opened · 13 closed · −$30M net 81% of book traded
- Stanley Druckenmiller - Duquesne Family Office 20 opened · 26 closed · −$387M net 78% of book traded
What they hold
Most owned counts managers, with the change since last quarter. Largest is the share of the combined book, by dollars, so the biggest books lead it. Highest conviction is the average position among holders, three or more.
Most owned
- 1 GOOGL / GOOG Alphabet 75 managers +5
- 2 MSFT Microsoft Corp. 64 managers +1
- 3 AMZN Amazon.com, Inc. 61 managers +8
- 4 META Meta Platforms Inc. 43 managers −9
- 5 TSM Taiwan Semiconductor Mfg Ltd 42 managers −1
- 6 NVDA Nvidia Corporation 40 managers +3
- 7 V Visa Inc. 36 managers +1
- 8 BRK.B / BRK.A Berkshire Hathaway 35 managers no change
- 9 DIS Disney Walt Co. 32 managers no change
- 10 UNH Unitedhealth Group, Inc. 31 managers −1
Largest
- 1 AAPL Apple Inc. 4.9% held by 30
- 2 GOOGL / GOOG Alphabet 3.9% held by 75
- 3 AXP American Express Co. 3.8% held by 18
- 4 MSFT Microsoft Corp. 3.0% held by 64
- 5 BAC Bank America Corp. 2.2% held by 22
- 6 AMZN Amazon.com, Inc. 2.2% held by 61
- 7 KO Coca Cola Co. 1.9% held by 11
- 8 V Visa Inc. 1.6% held by 36
- 9 META Meta Platforms Inc. 1.6% held by 43
- 10 TSM Taiwan Semiconductor Mfg Ltd 1.6% held by 42
Highest conviction
- 1 HHH Howard Hughes Holdings Inc. avg 20.1% held by 5
- 2 CVNA Carvana Co. Cl A avg 13.9% held by 15
- 3 JHG Janus Henderson Group PLC avg 13.1% held by 3
- 4 EQH Equitable Hldgs Inc. avg 11.3% held by 3
- 5 MDGL Madrigal Pharmaceuticals Inc. avg 10.2% held by 3
- 6 SNX Td Synnex Corporation avg 10.0% held by 5
- 7 BRK.B / BRK.A Berkshire Hathaway avg 9.5% held by 35
- 8 RIG Transocean Ltd avg 9.3% held by 3
- 9 TDG Transdigm Group Inc. avg 9.1% held by 8
- 10 IBKR Interactive Brokers Group In avg 8.4% held by 6
Did the combined book beat SPY?
Each quarter’s combined book held to the next quarter-end, at the 13Fs’ own prices. Price only, no dividends, and today’s managers throughout. Nobody could have copied it: 13Fs arrive about 45 days after the quarter ends.
Combined book, 8 quarters
+33.3%
SPY
+37.2%
Difference
−3.9 pts
2024 Q2, the start
+0.0% Combined book
+0.0% SPY
2024 Q3, since 2024 Q2
+6.9% Combined book
+5.4% SPY
That quarter: book +6.9%, SPY +5.4%
2024 Q4, since 2024 Q2
+8.1% Combined book
+7.7% SPY
That quarter: book +1.1%, SPY +2.1%
2025 Q1, since 2024 Q2
+6.0% Combined book
+2.8% SPY
That quarter: book −2.0%, SPY −4.6%
2025 Q2, since 2024 Q2
+14.5% Combined book
+13.5% SPY
That quarter: book +8.0%, SPY +10.5%
2025 Q3, since 2024 Q2
+21.7% Combined book
+22.4% SPY
That quarter: book +6.3%, SPY +7.8%
2025 Q4, since 2024 Q2
+24.9% Combined book
+25.3% SPY
That quarter: book +2.6%, SPY +2.4%
2026 Q1, since 2024 Q2
+19.6% Combined book
+19.5% SPY
That quarter: book −4.2%, SPY −4.6%
2026 Q2, since 2024 Q2
+33.3% Combined book
+37.2% SPY
That quarter: book +11.5%, SPY +14.8%
Quarter by quarter
| Quarter | Each manager once | By dollars | SPY | Book − SPY | Managers |
|---|---|---|---|---|---|
| 2026 Q2 | +14.5% | +11.5% | +14.8% | −3.4 pts | 133 |
| 2026 Q1 | −4.4% | −4.2% | −4.6% | +0.4 pts | 136 |
| 2025 Q4 | +2.1% | +2.6% | +2.4% | +0.2 pts | 136 |
| 2025 Q3 | +9.1% | +6.3% | +7.8% | −1.5 pts | 136 |
| 2025 Q2 | +11.6% | +8.0% | +10.5% | −2.4 pts | 136 |
| 2025 Q1 | −3.8% | −2.0% | −4.6% | +2.6 pts | 136 |
| 2024 Q4 | +2.6% | +1.1% | +2.1% | −1.0 pts | 134 |
| 2024 Q3 | +7.5% | +6.9% | +5.4% | +1.5 pts | 133 |
All 2,506 names
Download CSVShowing 300 of 394 matching names. The CSV has every name.
| Ticker | Company | Sector | Held by | Weight, $ | Net bought | Bought / sold | Opened / closed |
|---|---|---|---|---|---|---|---|
| UNH | Unitedhealth Group, Inc. | Health Care | 31 −1 | 0.62% | +$53M | 8 / 11 | 2 / 3 |
| TMO | Thermo Fisher Scientific Inc. | Health Care | 22 +1 | 0.14% | −$99M | 5 / 10 | 2 / 1 |
| DHR | Danaher Corporation | Health Care | 19 −1 | 0.06% | −$862M | 4 / 10 | 2 / 3 |
| JNJ | Johnson & Johnson | Health Care | 17 +1 | 0.05% | −$61M | 2 / 5 | 2 / 1 |
| CVS | Cvs Health Corp. | Health Care | 14 −1 | 0.56% | −$823M | 2 / 6 | 0 / 1 |
| ELV | Elevance Health Inc. Formerly | Health Care | 14 | 0.46% | +$320M | 2 / 4 | 0 / 0 |
| GEHC | Ge Healthcare Technologies, Inc. | Health Care | 13 +3 | 0.28% | +$920M | 7 / 0 | 3 / 0 |
| CI | The Cigna Group | Health Care | 12 | 0.39% | +$550M | 6 / 2 | 0 / 0 |
| MRK | Merck & Co. Inc. | Health Care | 12 | 0.11% | +$437M | 1 / 2 | 0 / 0 |
| PFE | Pfizer Inc. | Health Care | 12 | 0.02% | −$10M | 1 / 4 | 0 / 0 |
| ABBV | Abbvie Inc. | Health Care | 12 −1 | 0.01% | −$12M | 1 / 4 | 0 / 1 |
| BSX | Boston Scientific Corp. | Health Care | 11 +2 | 0.16% | +$311M | 3 / 4 | 2 / 0 |
| LLY | Eli Lilly & Co. | Health Care | 11 +1 | 0.14% | −$625M | 1 / 2 | 1 / 0 |
| MDT | Medtronic PLC | Health Care | 11 | 0.14% | −$270M | 0 / 4 | 0 / 0 |
| BMY | Bristol-Myers Squibb Co. | Health Care | 11 | 0.09% | +$165M | 5 / 5 | 2 / 2 |
| ABT | Abbott Labs | Health Care | 11 | 0.06% | −$507M | 0 / 2 | 0 / 0 |
| ZBH | Zimmer Biomet Holdings, Inc. | Health Care | 10 −1 | 0.22% | +$667M | 3 / 6 | 0 / 1 |
| ICLR | Icon PLC | Health Care | 10 | 0.08% | +$53M | 3 / 4 | 2 / 2 |
| WST | West Pharmaceutical Svsc Inc. | Health Care | 10 | 0.06% | −$47M | 3 / 7 | 3 / 3 |
| HCA | Hca Healthcare Inc. | Health Care | 9 | 0.50% | −$441M | 1 / 3 | 0 / 0 |
| IQV | Iqvia Hldgs Inc. | Health Care | 9 +1 | 0.22% | −$159M | 3 / 2 | 2 / 1 |
| BAX | Baxter Intl Inc. | Health Care | 9 | 0.18% | +$305M | 4 / 3 | 1 / 1 |
| NTRA | Natera Inc. | Health Care | 9 | 0.16% | +$185M | 1 / 7 | 0 / 0 |
| MDLN | Medline Inc. IPO or spin-off | Health Care | 9 +9 | 0.08% | +$1.2B | 9 / 0 | 9 / 0 |
| GSK | Gsk PLC | Health Care | 8 | 0.22% | −$555M | 1 / 5 | 0 / 0 |
| BDX | Becton Dickinson & Co. | Health Care | 8 | 0.22% | +$408M | 2 / 4 | 0 / 0 |
| NVS | Novartis AG | Health Care | 8 +1 | 0.08% | −$216M | 2 / 2 | 1 / 0 |
| ISRG | Intuitive Surgical Inc. | Health Care | 8 +4 | 0.08% | +$726M | 6 / 0 | 4 / 0 |
| TEVA | Teva Pharmaceutical Inds Ltd | Health Care | 8 −2 | 0.06% | −$769M | 1 / 8 | 0 / 2 |
| AMGN | Amgen Inc. | Health Care | 8 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| REGN | Regeneron Pharmaceuticals, Inc. | Health Care | 7 | 0.25% | +$89M | 2 / 1 | 0 / 0 |
| IDXX | Idexx Labs Inc. | Health Care | 7 | 0.21% | −$683M | 0 / 4 | 0 / 0 |
| THC | Tenet Healthcare Corp. | Health Care | 7 +1 | 0.06% | +$279M | 1 / 3 | 1 / 0 |
| TECH | Bio-Techne Corp. | Health Care | 7 | 0.05% | +$26M | 3 / 1 | 0 / 0 |
| DGX | Quest Diagnostics Inc. | Health Care | 7 | 0.02% | +$41M | 2 / 0 | 0 / 0 |
| BIIB | Biogen Inc. | Health Care | 7 +1 | 0.02% | +$73M | 2 / 2 | 1 / 0 |
| NVO | Novo-Nordisk A S | Health Care | 7 +1 | 0.01% | +$44M | 4 / 1 | 1 / 0 |
| CAH | Cardinal Health Inc. | Health Care | 7 | <0.01% | +$66M | 1 / 2 | 0 / 0 |
| SOLV | Solventum Corporation | Health Care | 6 | 0.08% | +$41M | 2 / 1 | 0 / 0 |
| VEEV | Veeva Sys Inc. | Health Care | 6 | 0.06% | −$106M | 0 / 3 | 0 / 0 |
| ILMN | Illumina Inc. | Health Care | 6 −1 | 0.06% | −$6M | 1 / 1 | 0 / 1 |
| CNC | Centene Corp. Del | Health Care | 6 +1 | 0.04% | +$103M | 4 / 0 | 1 / 0 |
| MCK | Mckesson Corp. | Health Care | 6 | 0.04% | −$58M | 1 / 4 | 0 / 0 |
| PTGX | Protagonist Therapeutics Inc. | Health Care | 6 +2 | 0.04% | +$5M | 2 / 0 | 2 / 0 |
| ROIV | Roivant Sciences Ltd | Health Care | 6 +2 | 0.01% | −$376M | 3 / 2 | 2 / 0 |
| ALKS | Alkermes PLC | Health Care | 6 | <0.01% | −$192K | 2 / 1 | 0 / 0 |
| HUM | Humana, Inc. | Health Care | 5 −1 | 0.26% | −$104M | 0 / 3 | 0 / 1 |
| SNY | Sanofi SA | Health Care | 5 | 0.18% | −$598M | 2 / 2 | 0 / 0 |
| AVTR | Avantor, Inc. | Health Care | 5 | 0.11% | −$2M | 1 / 1 | 0 / 0 |
| SYK | Stryker Corporation | Health Care | 5 −1 | 0.10% | −$494M | 0 / 5 | 0 / 1 |
| ZTS | Zoetis Inc. | Health Care | 5 −4 | 0.08% | −$515M | 3 / 7 | 1 / 5 |
| NVST | Envista Holdings Corporation | Health Care | 5 | 0.03% | −$50M | 1 / 1 | 0 / 0 |
| BNTX | Biontech Se | Health Care | 5 | 0.02% | −$2M | 1 / 1 | 0 / 0 |
| INSM | Insmed Inc. | Health Care | 5 −1 | 0.02% | −$277M | 1 / 2 | 0 / 1 |
| MEDP | Medpace Holdings Inc. | Health Care | 5 | 0.02% | −$112M | 0 / 3 | 0 / 0 |
| ACHC | Acadia Healthcare Company In | Health Care | 5 −1 | 0.02% | −$25M | 3 / 3 | 1 / 2 |
| HSIC | Henry Schein, Inc. | Health Care | 5 +1 | 0.02% | +$25M | 1 / 2 | 1 / 0 |
| IONS | Ionis Pharmaceuticals Inc. | Health Care | 5 | 0.02% | −$50M | 1 / 2 | 0 / 0 |
| BLCO | Bausch Plus Lomb Corp. | Health Care | 5 | 0.01% | +$20M | 2 / 1 | 0 / 0 |
| GILD | Gilead Sciences, Inc. | Health Care | 4 | 0.21% | −$474M | 1 / 2 | 0 / 0 |
| BBIO | Bridgebio Pharma Inc. | Health Care | 4 +1 | 0.12% | −$58M | 3 / 1 | 1 / 0 |
| WAT | Waters Corp. | Health Care | 4 +1 | 0.11% | −$170M | 1 / 3 | 1 / 0 |
| BMRN | Biomarin Pharmaceutical, Inc. | Health Care | 4 | 0.09% | −$136M | 1 / 1 | 0 / 0 |
| BIO | Bio Rad Labs Inc. | Health Care | 4 | 0.08% | +$838K | 0 / 1 | 0 / 0 |
| VTRS | Viatris Inc. | Health Care | 4 | 0.07% | +$145M | 3 / 0 | 0 / 0 |
| MTD | Mettler Toledo International | Health Care | 4 +1 | 0.07% | −$31M | 1 / 1 | 1 / 0 |
| ALNY | Alnylam Pharmaceuticals, Inc. | Health Care | 4 −2 | 0.05% | −$148M | 1 / 4 | 1 / 3 |
| CRL | Charles Riv Labs Intl Inc. | Health Care | 4 +1 | 0.04% | +$30M | 2 / 0 | 1 / 0 |
| ADPT | Adaptive Biotechnologies Cor | Health Care | 4 +1 | 0.03% | −$16M | 2 / 1 | 1 / 0 |
| WGS | Genedx Holdings Corp. | Health Care | 4 | 0.03% | +$28M | 2 / 1 | 0 / 0 |
| A | Agilent Technologies Inc. | Health Care | 4 | 0.03% | −$172M | 1 / 2 | 1 / 1 |
| COO | Cooper Cos Inc. | Health Care | 4 | 0.02% | +$44M | 2 / 1 | 0 / 0 |
| NAMS | Newamsterdam Pharma Company | Health Care | 4 +1 | 0.02% | −$25M | 3 / 1 | 1 / 0 |
| RPRX | Royalty Pharma PLC | Health Care | 4 | 0.02% | +$6M | 2 / 1 | 0 / 0 |
| ALGN | Align Technology Inc. | Health Care | 4 | 0.01% | +$184M | 3 / 2 | 1 / 1 |
| TFX | Teleflex Incorporated | Health Care | 4 +1 | 0.01% | +$27M | 3 / 0 | 1 / 0 |
| LH | Labcorp Holdings Inc. | Health Care | 4 | <0.01% | −$9M | 1 / 2 | 0 / 0 |
| CDNA | Caredx Inc. | Health Care | 4 | <0.01% | +$4M | 2 / 0 | 0 / 0 |
| RDNT | Radnet Inc. | Health Care | 4 | <0.01% | +$28M | 1 / 0 | 0 / 0 |
| BTI | British Amern Tob PLC | Health Care | 4 | <0.01% | +$8M | 2 / 1 | 0 / 0 |
| OSCR | Oscar Health Inc. | Health Care | 4 −2 | <0.01% | −$66M | 0 / 5 | 0 / 2 |
| HQY | Healthequity Inc. | Health Care | 4 +1 | <0.01% | −$634K | 1 / 1 | 1 / 0 |
| NUVB | Nuvation Bio Inc. | Health Care | 4 +1 | <0.01% | −$4M | 1 / 1 | 1 / 0 |
| VRTX | Vertex Pharmaceuticals | Health Care | 4 −1 | <0.01% | −$33M | 0 / 2 | 0 / 1 |
| INSP | Inspire Med Sys Inc. | Health Care | 4 +1 | <0.01% | +$13M | 2 / 2 | 1 / 0 |
| EHC | Encompass Health Corp. | Health Care | 4 −1 | <0.01% | −$55M | 0 / 3 | 0 / 1 |
| STOK | Stoke Therapeutics Inc. | Health Care | 4 +1 | <0.01% | −$2M | 1 / 2 | 1 / 0 |
| SNDX | Syndax Pharmaceuticals Inc. | Health Care | 4 +1 | <0.01% | +$305K | 2 / 1 | 1 / 0 |
| EW | Edwards Lifesciences Corp. | Health Care | 4 −1 | <0.01% | −$262M | 1 / 1 | 0 / 1 |
| PGNY | Progyny Inc. | Health Care | 4 +1 | <0.01% | +$9M | 2 / 0 | 1 / 0 |
| KPTI | Karyopharm Therapeutics Inc. | Health Care | 4 +3 | <0.01% | +$10M | 3 / 0 | 3 / 0 |
| URGN | Urogen Pharma Ltd | Health Care | 4 | <0.01% | +$6M | 1 / 1 | 1 / 1 |
| ASND | Ascendis Pharma A/S | Health Care | 4 −1 | <0.01% | −$4M | 0 / 3 | 0 / 1 |
| ELAN | Elanco Animal Health, Inc. | Health Care | 3 +1 | 0.12% | −$80M | 2 / 0 | 1 / 0 |
| UHS | Universal Hlth Svcs Inc. | Health Care | 3 −2 | 0.10% | −$111M | 1 / 4 | 0 / 2 |
| INCY | Incyte Corp. | Health Care | 3 | 0.09% | −$59M | 1 / 1 | 0 / 0 |
| RVMD | Revolution Medicines Inc. | Health Care | 3 | 0.08% | −$8M | 0 / 1 | 0 / 0 |
| MDGL | Madrigal Pharmaceuticals Inc. | Health Care | 3 | 0.07% | −$117M | 0 / 1 | 0 / 0 |
| ALC | Alcon AG | Health Care | 3 | 0.06% | −$14M | 1 / 1 | 0 / 0 |
| NBIX | Neurocrine Biosciences, Inc. | Health Care | 3 | 0.05% | −$7M | 0 / 0 | 0 / 0 |
| EXEL | Exelixis Inc. | Health Care | 3 | 0.05% | −$167M | 0 / 3 | 0 / 0 |
| BEAM | Beam Therapeutics Inc. | Health Care | 3 −2 | 0.04% | +$36M | 1 / 2 | 0 / 2 |
| CRSP | Crispr Therapeutics AG | Health Care | 3 | 0.04% | +$39M | 1 / 0 | 0 / 0 |
| BHC | Bausch Health Cos Inc. | Health Care | 3 | 0.03% | +$19M | 2 / 0 | 0 / 0 |
| LQDA | Liquidia Corporation | Health Care | 3 +1 | 0.03% | −$2M | 1 / 1 | 1 / 0 |
| INDV | Indivior Pharmaceuticals Inc. | Health Care | 3 | 0.02% | −$7M | 0 / 2 | 0 / 0 |
| SGRY | Surgery Partners Inc. | Health Care | 3 | 0.02% | +$57M | 3 / 1 | 1 / 1 |
| ADMA | Adma Biologics Inc. | Health Care | 3 +2 | 0.02% | +$87M | 3 / 0 | 2 / 0 |
| XRAY | Dentsply Sirona Inc. | Health Care | 3 +1 | 0.02% | +$67M | 2 / 0 | 1 / 0 |
| GRAL | Grail Inc. | Health Care | 3 | 0.01% | +$85M | 1 / 1 | 0 / 0 |
| VCYT | Veracyte Inc. | Health Care | 3 | 0.01% | −$24M | 0 / 1 | 0 / 0 |
| SDGR | Schrodinger Inc. | Health Care | 3 | 0.01% | +$468K | 1 / 1 | 0 / 0 |
| FOLD | Amicus Therapeutics Inc. | Health Care | 3 +1 | <0.01% | +$69M | 1 / 1 | 1 / 0 |
| Masimo | Masimo Corp. | Health Care | 3 | <0.01% | −$155M | 1 / 2 | 1 / 1 |
| ORKA | Oruka Therapeutics Inc. | Health Care | 3 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| ENTA | Enanta Pharmaceuticals Inc. | Health Care | 3 +1 | <0.01% | +$22M | 3 / 0 | 1 / 0 |
| GH | Guardant Health Inc. | Health Care | 3 | <0.01% | −$20K | 2 / 1 | 0 / 0 |
| BFLY | Butterfly Network Inc. | Health Care | 3 +1 | <0.01% | +$19M | 2 / 0 | 1 / 0 |
| CGON | Cg Oncology Inc. | Health Care | 3 | <0.01% | −$5M | 0 / 1 | 0 / 0 |
| PGEN | Precigen Inc. | Health Care | 3 +2 | <0.01% | −$32M | 2 / 1 | 2 / 0 |
| ESTA | Establishment Labs Hldgs Inc. | Health Care | 3 +1 | <0.01% | −$40M | 2 / 2 | 2 / 1 |
| SRTA | Strata Critical Medical Inc. | Health Care | 3 | <0.01% | +$5M | 2 / 0 | 0 / 0 |
| HOLX | Hologic Inc. | Health Care | 3 | <0.01% | −$45M | 2 / 3 | 2 / 2 |
| BKD | Brookdale Sr Living Inc. | Health Care | 3 +1 | <0.01% | +$37M | 2 / 0 | 1 / 0 |
| EMBC | Embecta Corp. | Health Care | 3 | <0.01% | +$869K | 1 / 0 | 0 / 0 |
| AXGN | Axogen Inc. | Health Care | 3 | <0.01% | −$9M | 0 / 2 | 0 / 0 |
| ANNX | Annexon Inc. | Health Care | 3 +2 | <0.01% | +$13M | 2 / 0 | 2 / 0 |
| SPRY | Ars Pharmaceuticals Inc. | Health Care | 3 +1 | <0.01% | +$7M | 2 / 0 | 1 / 0 |
| DXCM | Dexcom Inc. | Health Care | 3 +1 | <0.01% | +$517K | 2 / 1 | 1 / 0 |
| CMPS | Compass Pathways PLC | Health Care | 3 +1 | <0.01% | +$1M | 1 / 0 | 1 / 0 |
| XENE | Xenon Pharmaceuticals Inc. | Health Care | 3 | <0.01% | +$2M | 1 / 1 | 1 / 1 |
| DNLI | Denali Therapeutics Inc. | Health Care | 3 +1 | <0.01% | +$7M | 3 / 0 | 1 / 0 |
| RARE | Ultragenyx Pharmaceutical In | Health Care | 3 +1 | <0.01% | +$6M | 3 / 1 | 2 / 1 |
| CATX | Perspective Therapeutics Inc. | Health Care | 3 +2 | <0.01% | +$6M | 3 / 0 | 2 / 0 |
| MIRM | Mirum Pharmaceuticals Inc. | Health Care | 3 | <0.01% | +$7M | 1 / 0 | 0 / 0 |
| VKTX | Viking Therapeutics Inc. | Health Care | 3 +1 | <0.01% | +$3M | 1 / 1 | 1 / 0 |
| COR | Cencora Inc. | Health Care | 3 −1 | <0.01% | −$604M | 0 / 2 | 0 / 1 |
| BCYC | Bicycle Therapeutics Plc-Adr | Health Care | 3 | <0.01% | −$4K | 0 / 0 | 0 / 0 |
| CELC | Celcuity Inc. | Health Care | 3 +2 | <0.01% | +$624K | 2 / 1 | 2 / 0 |
| MOH | Molina Healthcare Inc. | Health Care | 2 +1 | 0.03% | +$50M | 1 / 1 | 1 / 0 |
| FMS | Fresenius Medical Care AG | Health Care | 2 | 0.03% | −$2M | 0 / 0 | 0 / 0 |
| OPCH | Option Care Health Inc. | Health Care | 2 | 0.02% | +$74M | 2 / 0 | 0 / 0 |
| CAI | Caris Life Sciences Inc. | Health Care | 2 −1 | 0.02% | −$6M | 1 / 1 | 0 / 1 |
| PBH | Prestige Consmr Healthcare I | Health Care | 2 | 0.02% | +$31M | 1 / 0 | 0 / 0 |
| TWST | Twist Bioscience Corp. | Health Care | 2 | 0.02% | +$26M | 1 / 0 | 0 / 0 |
| SHC | Sotera Health Co. | Health Care | 2 | 0.01% | +$71M | 2 / 0 | 0 / 0 |
| CNTA | Centessa Pharmaceuticals PLC | Health Care | 2 +1 | 0.01% | +$67M | 2 / 0 | 1 / 0 |
| WVE | Wave Life Sciences Ltd | Health Care | 2 | 0.01% | +$13M | 2 / 1 | 1 / 1 |
| AGIO | Agios Pharmaceuticals Inc. | Health Care | 2 | <0.01% | −$18M | 0 / 2 | 0 / 0 |
| BBNX | Beta Bionics Inc. | Health Care | 2 | <0.01% | +$625K | 1 / 0 | 0 / 0 |
| SION | Sionna Therapeutics Inc. | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| HIMS | Hims & Hers Health Inc. | Health Care | 2 −1 | <0.01% | −$238M | 1 / 2 | 0 / 1 |
| NVAX | Novavax Inc. | Health Care | 2 −1 | <0.01% | −$11M | 1 / 2 | 0 / 1 |
| RGEN | Repligen Corp. | Health Care | 2 | <0.01% | +$31M | 2 / 0 | 0 / 0 |
| DOCS | Doximity Inc. | Health Care | 2 −2 | <0.01% | +$9M | 1 / 3 | 0 / 2 |
| COGT | Cogent Biosciences Inc. | Health Care | 2 | <0.01% | +$41M | 1 / 0 | 0 / 0 |
| UTHR | United Therapeutics Corp. | Health Care | 2 | <0.01% | −$3M | 0 / 1 | 0 / 0 |
| ACAD | Acadia Pharmaceuticals Inc. | Health Care | 2 | <0.01% | −$528K | 0 / 1 | 0 / 0 |
| PSNL | Personalis Inc. | Health Care | 2 +1 | <0.01% | +$156K | 1 / 0 | 1 / 0 |
| PCVX | Vaxcyte Inc. | Health Care | 2 +1 | <0.01% | +$3M | 2 / 0 | 1 / 0 |
| ENOV | Enovis Corporation | Health Care | 2 | <0.01% | −$3M | 0 / 2 | 0 / 0 |
| PHG | Koninklijke Philips NV | Health Care | 2 | <0.01% | +$7M | 2 / 0 | 0 / 0 |
| RMD | Resmed Inc. | Health Care | 2 | <0.01% | −$7K | 0 / 0 | 0 / 0 |
| ABVX | Abivax SA | Health Care | 2 | <0.01% | −$55M | 1 / 1 | 0 / 0 |
| ORIC | Oric Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$297K | 1 / 0 | 0 / 0 |
| JAZZ | Jazz Pharmaceuticals PLC | Health Care | 2 | <0.01% | −$44M | 0 / 1 | 0 / 0 |
| TRVI | Trevi Therapeutics Inc. | Health Care | 2 | <0.01% | −$25M | 0 / 2 | 0 / 0 |
| MMSI | Merit Med Sys Inc. | Health Care | 2 | <0.01% | −$99M | 0 / 1 | 0 / 0 |
| IRON | Disc Medicine Inc. | Health Care | 2 | <0.01% | +$8M | 1 / 0 | 0 / 0 |
| GPCR | Structure Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$30M | 1 / 1 | 1 / 0 |
| MLYS | Mineralys Therapeutics Inc. | Health Care | 2 | <0.01% | −$32M | 0 / 2 | 0 / 0 |
| DNA | Ginkgo Bioworks Holdings Inc. | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| DYN | Dyne Therapeutics Inc. | Health Care | 2 | <0.01% | +$4M | 1 / 0 | 0 / 0 |
| ATRC | Atricure Inc. | Health Care | 2 +1 | <0.01% | +$5M | 1 / 0 | 1 / 0 |
| JBIO | Jade Biosciences Inc. | Health Care | 2 +1 | <0.01% | +$11M | 2 / 0 | 1 / 0 |
| GRFS | Grifols S A | Health Care | 2 | <0.01% | −$411K | 0 / 0 | 0 / 0 |
| SUPN | Supernus Pharmaceuticals Inc. | Health Care | 2 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| CYTK | Cytokinetics Inc. | Health Care | 2 | <0.01% | −$2M | 1 / 2 | 1 / 1 |
| PRME | Prime Medicine Inc. | Health Care | 2 | <0.01% | −$13M | 0 / 1 | 0 / 0 |
| LKFT | Galapagos NV | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| OCUL | Ocular Therapeutix Inc. | Health Care | 2 +1 | <0.01% | +$219K | 1 / 0 | 1 / 0 |
| IOVA | Iovance Biotherapeutics Inc. | Health Care | 2 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| TMDX | Transmedics Group Inc. Com | Health Care | 2 | <0.01% | +$625K | 1 / 0 | 0 / 0 |
| VSTM | Verastem Inc. IPO or spin-off | Health Care | 2 +2 | <0.01% | +$17M | 2 / 0 | 2 / 0 |
| EWTX | Edgewise Therapeutics Inc. | Health Care | 2 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| ATEC | Alphatec Hldgs Inc. | Health Care | 2 | <0.01% | +$464K | 1 / 0 | 0 / 0 |
| QURE | Uniqure NV | Health Care | 2 +1 | <0.01% | +$3M | 1 / 1 | 1 / 0 |
| ARQT | Arcutis Biotherapeutics Inc. | Health Care | 2 | <0.01% | +$8M | 1 / 1 | 1 / 1 |
| AORT | Artivion Inc. | Health Care | 2 +1 | <0.01% | −$376K | 1 / 1 | 1 / 0 |
| BLLN | Billiontoone Inc. IPO or spin-off | Health Care | 2 +2 | <0.01% | +$15M | 2 / 0 | 2 / 0 |
| MBX | Mbx Biosciences Inc. | Health Care | 2 | <0.01% | +$3M | 1 / 0 | 0 / 0 |
| RCKT | Rocket Pharmaceuticals Inc. | Health Care | 2 +1 | <0.01% | −$18M | 1 / 1 | 1 / 0 |
| VNDA | Vanda Pharmaceuticals Inc. | Health Care | 2 | <0.01% | −$10K | 0 / 0 | 0 / 0 |
| BCAX | Bicara Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$4M | 1 / 1 | 1 / 0 |
| MRVI | Maravai Lifesciences Hldgs I | Health Care | 2 | <0.01% | +$4M | 1 / 0 | 0 / 0 |
| CAPR | Capricor Therapeutics Inc. | Health Care | 2 +1 | <0.01% | +$7M | 1 / 0 | 1 / 0 |
| TSHA | Taysha Gene Therapies Inc. | Health Care | 2 +1 | <0.01% | +$516K | 1 / 1 | 1 / 0 |
| PROF | Profound Med Corp. | Health Care | 2 +1 | <0.01% | +$2M | 2 / 0 | 1 / 0 |
| TVTX | Travere Therapeutics Inc. | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| PODD | Insulet Corp. | Health Care | 2 | <0.01% | +$621K | 1 / 0 | 0 / 0 |
| IMVT | Immunovant Inc. | Health Care | 2 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| PRQR | Proqr Therapeutics N V | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BCRX | Biocryst Pharmaceuticals Inc. | Health Care | 2 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| KRYS | Krystal Biotech | Health Care | 2 | <0.01% | +$21K | 0 / 0 | 0 / 0 |
| AXSM | Axsome Therapeutics | Health Care | 2 | <0.01% | −$479K | 0 / 1 | 0 / 0 |
| KURA | Kura Oncology Inc. | Health Care | 2 +1 | <0.01% | −$1M | 1 / 1 | 1 / 0 |
| Inmode | Inmode Ltd | Health Care | 2 +1 | <0.01% | +$1M | 1 / 0 | 1 / 0 |
| ALVO | Alvotech SA | Health Care | 2 | <0.01% | −$4M | 0 / 1 | 0 / 0 |
| HALO | Halozyme Therapeutics | Health Care | 2 | <0.01% | +$12K | 0 / 0 | 0 / 0 |
| BWAY | Brainsway Ltd | Health Care | 2 +1 | <0.01% | +$2M | 1 / 1 | 1 / 0 |
| ALLO | Allogene Therapeutics Inc. | Health Care | 2 | <0.01% | −$1K | 0 / 0 | 0 / 0 |
| SRRK | Scholar Rock Hldg Corp. | Health Care | 2 | <0.01% | +$163K | 1 / 0 | 0 / 0 |
| NUVL | Nuvalent Inc. | Health Care | 2 +1 | <0.01% | +$640K | 1 / 0 | 1 / 0 |
| Compugen | Compugen Ltd | Health Care | 2 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| DVA | Davita Inc. | Health Care | 1 | 0.24% | −$46M | 0 / 0 | 0 / 0 |
| LNTH | Lantheus Hldgs Inc. | Health Care | 1 | 0.02% | +$130M | 1 / 0 | 0 / 0 |
| CRNX | Crinetics Pharmaceuticals In | Health Care | 1 | 0.02% | +$54M | 1 / 0 | 0 / 0 |
| PRVA | Privia Health Group Inc. | Health Care | 1 | 0.02% | +$9M | 0 / 0 | 0 / 0 |
| HROW | Harrow Health Inc. | Health Care | 1 | 0.01% | $0 | 0 / 0 | 0 / 0 |
| RXRX | Recursion Pharmaceuticals Inc. | Health Care | 1 | 0.01% | +$15M | 1 / 0 | 0 / 0 |
| ARGX | Argenx Se | Health Care | 1 | <0.01% | −$12M | 0 / 1 | 0 / 0 |
| TNGX | Tango Therapeutics Inc. | Health Care | 1 | <0.01% | +$20M | 1 / 0 | 0 / 0 |
| INBX | Inhibrx Biosciences Inc. | Health Care | 1 | <0.01% | −$28M | 0 / 1 | 0 / 0 |
| PHVS | Pharvaris N V | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| DNTH | Dianthus Therapeutics Inc. | Health Care | 1 | <0.01% | −$45M | 0 / 1 | 0 / 0 |
| Catalyst Pharmaceutic… | Catalyst Pharmaceuticals Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| FTRE | Fortrea Hldgs Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| HTFL | Heartflow Inc. | Health Care | 1 −1 | <0.01% | +$29M | 1 / 1 | 0 / 1 |
| TYRA | Tyra Biosciences Inc. | Health Care | 1 | <0.01% | +$24M | 1 / 0 | 0 / 0 |
| ETON | Eton Pharmaceuticals Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| IVVD | Invivyd Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| WAY | Waystar Hldg Corp. | Health Care | 1 −1 | <0.01% | +$10M | 1 / 2 | 1 / 2 |
| ABSI | Absci Corp. | Health Care | 1 | <0.01% | +$1M | 0 / 0 | 0 / 0 |
| ASMB | Assembly Biosciences Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| NEOG | Neogen Corp. | Health Care | 1 | <0.01% | −$9M | 0 / 1 | 0 / 0 |
| CERS | Cerus Corp. | Health Care | 1 | <0.01% | −$1M | 0 / 0 | 0 / 0 |
| RYTM | Rhythm Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$14M | 0 / 1 | 0 / 0 |
| ANAB | Anaptysbio Inc. | Health Care | 1 | <0.01% | +$801K | 0 / 0 | 0 / 0 |
| STXS | Stereotaxis Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| NRIX | Nurix Therapeutics Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| LFCR | Lifecore Biomedical Inc. | Health Care | 1 | <0.01% | −$100K | 0 / 0 | 0 / 0 |
| APGE | Apogee Therapeutics Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| SNWV | Sanuwave Health Inc. | Health Care | 1 | <0.01% | +$38K | 0 / 0 | 0 / 0 |
| MYGN | Myriad Genetics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| OGN | Organon & Co. | Health Care | 1 | <0.01% | +$90K | 0 / 0 | 0 / 0 |
| TERN | Terns Pharmaceuticals Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$26M | 1 / 0 | 1 / 0 |
| ZLAB | Zai Lab Ltd | Health Care | 1 | <0.01% | +$825K | 0 / 0 | 0 / 0 |
| PEPG | Pepgen Inc. | Health Care | 1 −1 | <0.01% | −$488K | 0 / 1 | 0 / 1 |
| USNA | Usana Health Sciences Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
| SNN | Smith & Nephew PLC | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| Enhabit | Enhabit Inc. | Health Care | 1 | <0.01% | −$431K | 0 / 0 | 0 / 0 |
| SLGL | Sol Gel Technologies | Health Care | 1 | <0.01% | +$10M | 1 / 0 | 0 / 0 |
| IDYA | Ideaya Biosciences Inc. | Health Care | 1 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| NVCR | Novocure Ltd | Health Care | 1 | <0.01% | +$553K | 0 / 0 | 0 / 0 |
| DMAC | Diamedica Therapeutics Inc. | Health Care | 1 | <0.01% | −$10M | 0 / 1 | 0 / 0 |
| ARCT | Arcturus Therapeutics Holdings | Health Care | 1 | <0.01% | +$5M | 1 / 0 | 0 / 0 |
| TGTX | Tg Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| RZLT | Rezolute Inc. | Health Care | 1 | <0.01% | +$13M | 1 / 0 | 0 / 0 |
| CBIO | Crescent Biopharma Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$14M | 1 / 0 | 1 / 0 |
| CMPX | Compass Therapeutics Inc. | Health Care | 1 | <0.01% | +$9M | 1 / 1 | 1 / 1 |
| ATAI | Atai Beckley NV IPO or spin-off | Health Care | 1 +1 | <0.01% | +$14M | 1 / 0 | 1 / 0 |
| PRTA | Prothena Corp. PLC | Health Care | 1 | <0.01% | −$34K | 0 / 0 | 0 / 0 |
| PNTG | Pennant Group Inc. | Health Care | 1 | <0.01% | +$162K | 0 / 0 | 0 / 0 |
| COYA | Coya Therapeutics Inc. | Health Care | 1 | <0.01% | +$2M | 1 / 0 | 0 / 0 |
| Bausch Lomb | Bausch Lomb Corp. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| BHVN | Biohaven Ltd | Health Care | 1 | <0.01% | +$8M | 1 / 0 | 0 / 0 |
| SIBN | Si-Bone Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| LFST | Lifestance Health Group Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| RCUS | Arcus Biosciences Inc. | Health Care | 1 | <0.01% | −$5M | 0 / 1 | 0 / 0 |
| CNTN | Tharimmune Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$10M | 1 / 0 | 1 / 0 |
| HSTM | Healthstream Inc. | Health Care | 1 | <0.01% | +$99K | 0 / 0 | 0 / 0 |
| NERV | Minerva Neurosciences Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$10M | 1 / 0 | 1 / 0 |
| COLL | Collegium Pharmaceutical Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| GUTS | Fractyl Health Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| CNTX | Context Therapeutics Inc. | Health Care | 1 | <0.01% | −$5M | 0 / 1 | 0 / 0 |
| TALK | Talkspace Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| TNDM | Tandem Diabetes Care Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| XOMA | Xoma Corp. Del | Health Care | 1 | <0.01% | +$997K | 1 / 0 | 0 / 0 |
| CON | Concentra Group Holdings Par | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| DERM | Journey Medical Corp. | Health Care | 1 | <0.01% | +$30K | 0 / 0 | 0 / 0 |
| INFU | Infusystem Hldgs Inc. | Health Care | 1 | <0.01% | −$453K | 0 / 1 | 0 / 0 |
| AVAH | Aveanna Healthcare Hldgs Inc. | Health Care | 1 −1 | <0.01% | −$11M | 0 / 1 | 0 / 1 |
| LZAGY | Lonza Group Adr | Health Care | 1 | <0.01% | −$280K | 0 / 0 | 0 / 0 |
| MRNA | Moderna Inc. | Health Care | 1 +1 | <0.01% | +$6M | 1 / 0 | 1 / 0 |
| Kalvista Pharmaceutic… | Kalvista Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| INGN | Inogen Inc. | Health Care | 1 | <0.01% | +$1M | 1 / 0 | 0 / 0 |
| SNDA | Sonida Senior Living Inc. Com IPO or spin-off | Health Care | 1 +1 | <0.01% | +$5M | 1 / 0 | 1 / 0 |
| ALMS | Alumis Inc. | Health Care | 1 | <0.01% | −$1M | 0 / 1 | 0 / 0 |
| ACRS | Aclaris Therapeutics Inc. | Health Care | 1 | <0.01% | $0 | 0 / 0 | 0 / 0 |
| VYGR | Voyager Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$5M | 1 / 0 | 1 / 0 |
| RLMD | Relmada Therapeutics Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$5M | 1 / 0 | 1 / 0 |
| TECX | Tectonic Therapeutics Inc. | Health Care | 1 | <0.01% | −$9M | 1 / 1 | 1 / 1 |
| PLX | Protalix Biotherapeutics Inc. | Health Care | 1 | <0.01% | −$184K | 0 / 0 | 0 / 0 |
| PEN | Penumbra Inc. | Health Care | 1 | <0.01% | +$132K | 0 / 0 | 0 / 0 |
| FBIO | Fortress Biotech Inc. IPO or spin-off | Health Care | 1 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| VMD | Viemed Healthcare Inc. | Health Care | 1 | <0.01% | +$300K | 1 / 0 | 0 / 0 |
| PRCT | Procept Biorobotics Corp. | Health Care | 1 +1 | <0.01% | +$4M | 1 / 0 | 1 / 0 |
| LRMR | Larimar Therapeutics Inc. | Health Care | 1 −1 | <0.01% | −$15M | 0 / 2 | 0 / 1 |
| ANGO | Angiodynamics Inc. | Health Care | 1 | <0.01% | −$123K | 0 / 0 | 0 / 0 |
| PHAT | Phathom Pharmaceuticals Inc. | Health Care | 1 | <0.01% | −$2M | 0 / 1 | 0 / 0 |
How the numbers work
Same managers in both quarters
Changes compare only managers with a 13F in both 2025 Q3 and 2025 Q4: 136 this time. New in 2025 Q4: Ning Jin - Avantyr Capital Partners.
Buying versus price
Each holding’s dollar change splits into price (what last quarter’s shares earned by this quarter’s 13F price) and net bought (shares added or cut, times this quarter’s price), using each 13F’s own values. The two add back to the change exactly. Stock splits are adjusted first.
Who counts as a buyer or a seller
A manager bought a stock if it opened a position, or added at least 5% to its shares or a trade worth 0.25% of its book; it sold if it closed the position or cut it by the same amounts. Smaller changes count as holding, and a stock split never counts. A manager was a net buyer for the quarter when its trading added up to at least 0.25% of its book. GOOG and GOOGL count once.
IPOs, spin-offs and mergers
A stock no tracked manager held last quarter (an IPO, a spin-off, a new share class) is not counted as buying, and one nobody holds now (a merger, a delisting) is not counted as selling. Choose them under All names to see them.
Each manager once, or by dollars
By default every manager counts the same, so a list leads with what the most managers did. By dollars ranks by money moved and weighs holdings by size, so the largest books set the order.
Sectors
GICS sectors where the company has one. Funds, foreign listings and private shares have none; their buying is shown on its own, never filed under Other. Sector weights are shares of the names that have a sector.
The combined book against SPY
Each quarter-end’s combined book is held to the next quarter-end at the 13Fs’ own prices: price only, no dividends, and today’s featured managers for every quarter. SPY is the same filings’ price for SPY. It is a record of what the managers held, not something anyone could have copied, because 13Fs arrive about 45 days after the quarter ends.
What a 13F leaves out
Long US-listed stock only: no shorts, cash, bonds or foreign listings, and options are left out here.